Results 161 to 170 of about 26,212 (200)

Retinal Detachment in the Setting of Neurofibromatosis Type 1. [PDF]

open access: yesJ Vitreoretin Dis
Pickel L   +4 more
europepmc   +1 more source

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Clinical Cancer Research, 2021
On April 10, 2020, the FDA approved selumetinib (KOSELUGO, AstraZeneca) for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.
Denise Casey   +27 more
semanticscholar   +1 more source

Selumetinib: the first ever approved drug for neurofibromatosis-1 related inoperable plexiform neurofibroma

Current Medical Research and Opinion, 2021
Plexiform neurofibroma (PN) is one of the most striking clinical features of neurofibromatosis 1. Growth of PN can occur at any stage of life but mostly in childhood and during hormonal changes.
S. Mukhopadhyay   +2 more
semanticscholar   +1 more source

Intestinal plexiform neurofibromas

Digestive and Liver Disease, 2008
a m A 6-year-old girl affected by type-1 neurofibromatosis NF1) presented with 1-month history of isolated abdominal ain. Physical examination revealed a palpable mass in the loer right abdominal section. Laboratory data were all normal. An abdominal ultrasound scan revealed a thickened wall f the last ileal loop and, under the liver, an image ...
CALLIGARIS L   +2 more
openaire   +3 more sources

Solitary Plexiform Neurofibroma

Dermatology, 1989
A 35-year-old man with a solitary subcutaneous cord running on the abdomen wall is reported. Histologic examination of the lesion permitted a diagnosis of plexiform neurofibroma. In this patient and in his family no other signs of von Recklinghausen’s disease were found.
F G, Aloi, R, Massobrio
openaire   +2 more sources

Home - About - Disclaimer - Privacy